Re: The waiting game.....
|
2
|
Resverlogix Corp.
|
Feb 13, 2019 09:20AM
|
Re: Amarin 3 or 5 point MACE
|
4
|
Resverlogix Corp.
|
Feb 13, 2019 09:08AM
|
Re: The waiting game.....
|
3
|
Resverlogix Corp.
|
Feb 13, 2019 06:53AM
|
Re: The waiting game.....
|
5
|
Resverlogix Corp.
|
Feb 12, 2019 08:29PM
|
Re: The waiting game.....
|
3
|
Resverlogix Corp.
|
Feb 12, 2019 06:23PM
|
Re: Dr. Mark Day interview with Proactive Investors at BIO CEO
|
2
|
BIOASIS TECHNOLOGIES INC
|
Feb 12, 2019 06:00PM
|
Re: The waiting game.....
|
3
|
Resverlogix Corp.
|
Feb 12, 2019 05:53PM
|
Re: Contest Tally
|
2
|
Resverlogix Corp.
|
Feb 12, 2019 03:06PM
|
BIO CEO Slides Up
|
1
|
Zenith Epigenetics
|
Feb 12, 2019 02:42PM
|
Re: The waiting game.....
|
1
|
Resverlogix Corp.
|
Feb 12, 2019 02:38PM
|
BIO CEO Slides Up
|
1
|
Resverlogix Corp.
|
Feb 12, 2019 02:14PM
|
Re: Dr. Mark Day interview with Proactive Investors at BIO CEO
|
1
|
BIOASIS TECHNOLOGIES INC
|
Feb 12, 2019 12:24PM
|
Re: Any thoughts to why BETonMACE patient median eGFR is so high?
|
2
|
Resverlogix Corp.
|
Feb 12, 2019 12:18PM
|
Re: Any thoughts to why BETonMACE patient median eGFR is so high?
|
1
|
Resverlogix Corp.
|
Feb 12, 2019 08:32AM
|
Dr. Mark Day interview with Proactive Investors at BIO CEO
|
1
|
BIOASIS TECHNOLOGIES INC
|
Feb 12, 2019 07:47AM
|
Re: Contest Tally
|
|
Resverlogix Corp.
|
Feb 11, 2019 09:19PM
|
Re: While we are waiting ...
|
2
|
Resverlogix Corp.
|
Feb 11, 2019 05:01PM
|
Re: Celgene inks $1B deal for a preclinical epigenetic blood cancer drug from Canada.
|
1
|
Zenith Epigenetics
|
Feb 10, 2019 10:07PM
|
Re: BETonMACE Enrollment
|
2
|
Resverlogix Corp.
|
Feb 09, 2019 09:12PM
|
Re: BETonMACE Enrollment
|
3
|
Resverlogix Corp.
|
Feb 09, 2019 03:52PM
|